106
Participants
Start Date
January 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Tolterodine tartrate extended release capsules
Desmopressin orally disintegrating tablets
Placebo orally disintegrating tablets
NEA Baptist Clinic, Jonesboro
Lynn Institute of The Ozarks, Little Rock
Moez Khorsandi, DO, Los Angeles
Urology Group of Southern California, Los Angeles
Riverside Clinical Research, Edgewater
Health Awareness, Inc., Jupiter
Pines Clinical Research, Inc., Pembroke Pines
Palm Beach Research Center, West Palm Beach
Clinical Research Atlanta, Stockbridge
Northshore Center for Gastroenterology, Evanston
Remedica, LLC, Rochester
The Urological Institute of Northeastern New York, Albany
Premier Medical Group of the Hudson Valley, P.C., Poughkeepsie
Parkhurst Research Organization, LLC, Bethany
Philadelphia Clinical Research, LLC, Philadelphia
Medical University of South Carolina, Charleston
Coastal Carolina Research Center, Mt. Pleasant
Vanderbilt University Medical Center, Nashville
Research Across America, Dallas
Advances in Health, Houston
Pioneer Research Solutions, Inc., Houston
Radiant Research, San Antonio
Clinical Research Associates of Tidewater, Norfolk
Seattle Women's: Health, Research, Gynecology, Seattle
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY